HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pulmonary sclerosing hemangioma of the lung. A type II pneumocytoma by immunohistochemical and immunoelectron microscopic studies.

Abstract
Three cases of pulmonary sclerosing hemangioma were studied by immunohistochemical and immunoelectron microscopic methods using a panel of antibodies. Six cases of adenocarcinoma of the lung, three cases of normal mesothelium, and three cases of mesothelioma were used as controls. The cytoplasm of some of the sclerosing hemangioma tumor cells was positive for the anti-lung surfactant apoprotein monoclonal antibody (PE-10). These cells were the pale cells of the solid areas, the cells covering the papillary projections, and the cells lining the cleft-like spaces. These cells also were positive for conventional epithelial cell markers. Some cells also were positive for vimentin. Electron microscopic study showed that the predominant cell was a poorly differentiated pneumocyte. Immunoelectron microscopic study also demonstrated that PE-10 existed in the rough endoplasmic reticulum of some of the cells in the solid areas, in the same way as normal type II pneumocytes. We concluded that the sclerosing hemangioma is an epithelial tumor with differentiation towards type II pneumocytes.
AuthorsY Satoh, E Tsuchiya, S Y Weng, T Kitagawa, T Matsubara, K Nakagawa, I Kinoshita, H Sugano
JournalCancer (Cancer) Vol. 64 Issue 6 Pg. 1310-7 (Sep 15 1989) ISSN: 0008-543X [Print] United States
PMID2548701 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apoproteins
  • Vimentin
Topics
  • Aged
  • Apoproteins (analysis)
  • Basement Membrane (ultrastructure)
  • Cell Membrane (ultrastructure)
  • Cytoplasm (ultrastructure)
  • Endoplasmic Reticulum (ultrastructure)
  • Female
  • Histiocytoma, Benign Fibrous (analysis, pathology)
  • Humans
  • Immunohistochemistry
  • Lung Neoplasms (analysis, pathology)
  • Microscopy, Electron
  • Middle Aged
  • Organelles (ultrastructure)
  • Vimentin (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: